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The matrix domain (MA) of human immunodeficiency virus type 1 Pr55
Gag is covalently modified
with a myristoyl group that mediates efficient viral production. However, the role of myristoylation,
particularly in the viral entry process, remains uninvestigated. This study replaced the
myristoylation signal of MA with a well-studied phosphatidylinositol 4,5-biphosphate-binding
plasma membrane (PM) targeting motif, the phospholipase C-d1 pleckstrin homology (PH)
domain. PH–Gag–Pol PM targeting and viral production efficiencies were improved compared
with Gag–Pol, consistent with the estimated increases in Gag–PM affinity. Both virions were
recovered in similar sucrose density-gradient fractions and had similar mature virion
morphologies. Importantly, PH–Gag–Pol and Gag–Pol pseudovirions had almost identical
infectivity, suggesting a dispensable role for myristoylation in the virus life cycle. PH–Gag–Pol
might be useful in separating the myristoylation-dependent processes from the myristoylation-
independent processes. This the first report demonstrating infectious pseudovirion production
without myristoylated Pr55
Gag.
The N-terminal region [p17
MA, matrix (MA) domain] of
human immunodeficiency virus type 1 (HIV-1) Pr55
Gag
(Gag), a structural protein with multiple roles in the virus
life cycle (Swanstrom & Wills, 1997), is covalently modified
with a myristyol group that aids in plasma membrane
(PM) targeting. Removal of this region leads to inefficient
Gag targeting to the PM, resulting in dramatically reduced
virus production (Bryant & Ratner, 1990; Go ¨ttlinger et al.,
1989; Pal et al., 1990; Zhou et al., 1994). Although viral
particles can be produced by substituting MA with
heterologous PM-targeting motifs, such substitution
mutants show markedly reduced infectivity (Jouvenet
et al., 2006; Scholz et al., 2008), probably due to an active
role of MA in viral entry (Kiernan et al., 1998; Wang et al.,
1993). However, direct experimental evidence of a viral
entry-specific role for MA myristoylation is lacking. Such
specific roles of Gag myristoylation can only be determined
by separating the myristoylation-dependent PM-targeting
function from other MA-associated functions.
We constructed a mutant gag expression plasmid where the
myristoylated region of Gag was replaced with the N-
terminal pleckstrin homology (PH) domain of phospho-
lipase C-d1 (PLCd1), a well-studied cellular PM-targeting
motif that functions similarly to the myristoyl moiety.
PLCd1 is a member of a family of inositol phospholipid-
specific PLC isozymes involved in transducer-mediated
intracellular responses (Berridge, 1993). The ~120 aa PH
domain can bind to phosphatidylinositol 4,5-biphosphate
[PI(4,5)P(2)] and localize to the PM with high affinity and
specificity (Ferguson et al., 1995b; Fiorentini et al., 2006;
Harlan et al., 1994, 1995; Rhee, 2001; Yagisawa et al., 1994),
and green fluorescent protein-bound PLCd1 PH domains
have been used to visualize the PM in living cells (Stauffer
et al., 1998; Tall et al., 2000).
We used a codon-optimized HIV-1 gag–pol expression
vector (pgag–pol) for genetic modification of gag,a sp gag–
pol increases Gag expression and facilitates protein analyses
(Wagner et al., 2000). The substituted mutant retained an
intact MA, with the exception of two N-terminal amino
acid mutations (ATGACTG and GGCAGCG), resulting
in an MGALA mutation to knock out the myristoylation
signal of Gag and prevent internal translational initiation
(Fig. 1a). The PLCd1 PH domain residues 1–175 (Stauffer
et al., 1998) were linked to the LA–Gag N terminus by the
amino acids PRAEFT, creating a PH–gag–pol expression
vector (pPH-gag-pol, Fig. 1a). A control PH domain
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(ESRKAAAAA; Fig. 1a); these residues are responsible
for the PH domain–PI(4,5)P(2) interaction (Ferguson et
al., 1995a). PH–Gag, PH4A–Gag and their cleaved
products were detected in transfected 293T cell lysates
with mouse monoclonal antibodies specific for the p24
CA
(capsid) domain (anti-p24
CA; NIH AIDS Research and
Reference Reagent Program) and MA domain (anti-p17
MA;
Advanced Biotechnologies) (Fig. 1b). PH–Gag cleavage was
more efficient than that of Gag, suggesting efficient PM
targeting of PH–Gag (Fig. 1b). The Gag protein levels in
the pPH4A-gag-pol-transfected cell lysate were higher than
those in pgag-pol- and pPH-gag-pol-transfected cell lysates
when adjusted for the amount of protein loaded, indicating
the low virus-like particle (VLP) production efficiency by
PH4A–Gag (Fig. 1b).
Fig. 1. Viral production by the gag–pol expression vectors. (a) The genetic structure of the pgag-pol, pPH-gag-pol and
pPH4A-gag-pol expression vectors, and the amino acid sequence of the PH–Gag junction are shown. The N-terminal PH
domain of PLCd1 (aa 1–175) was fused to LA–Gag, linked by a 5 aa spacer (shown in grey). The MGALA mutation to knock
out the myristoylation signal of Gag (myr signal k.o.) is underlined. Four alanine mutations were introduced to replace the ESRK
sequence (dotted line) to create the PH4A mutant. (b) Protein expression from pgag-pol (WT), pPH-gag-pol (PH) and pPH4A-
gag-pol (PH4A) in transfected 293T cell lysates and Gag cleavage in the virions were examined by Western blot analysis using
anti-p24
CA or anti-p17
MA antibodies. Note that the anti-p17
MA antibody recognizes the cleaved p17
MA protein only. The band
denoted as PH–MA–CA in the virion detected by the anti-p24
CA antibody (lower left panel) possibly overlaps with a faint Gag
signal derived from PH–Gag and PH4A–Gag from which the PH and PH4A domains have been cleaved. (c)
Immunofluorescence assay showing the distribution of Gag, PH–Gag and PH4A–Gag in 293T cells transfected with the
respective expression plasmid. Red and blue represent p24
CA and the Hoechst 33258-stained nucleus, respectively. Bars,
10 mm.
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Gag was analysed by immunofluorescence microscopy of
transfected 293T cells (Fig. 1c). Transfected cells were
grown for 24 h, fixed (4% formaldehyde), permeabilized
(0.1% Triton X-100 for 5–30 min) and incubated with
mouse anti-p24
CA and goat anti-mouse antibodies (GE
Healthcare Bio-Sciences) conjugated to streptavidin–Alexa
Fluor 555 (Invitrogen). Cells were stained with Hoechst
33258, mounted and analysed using confocal microscopy
as described previously (Futahashi et al., 2007). Gag was
found to be distributed throughout the cytoplasm and at
the cell periphery. In contrast, PH–Gag signals were mostly
detected at the cell periphery and PH4A–Gag was
distributed homogeneously in the cytoplasm. These data
clearly showed that PH–Gag targeted the PM more
efficiently than Gag, consistent with the Western blot
analysis (Fig. 1b). These results also suggested that the
efficient PM targeting of PH–Gag depends on the ability of
the PH domain to bind PI(4,5)P(2). Similar observations
were made in NP2 and COS7 cells.
VLP production was also examined. Tissue culture super-
natants of pgag-pol-, pPH-gag-pol- or pPH4A-gag-pol-
transfected 293T cells were passed through nitrocellulose
filters (0.45 mm) and the virions were collected by
centrifugation (541000 g for 1 h). Viral antigens, except
for PH4A, were detected with anti-p24
CA and anti-p17
MA
antibodies (Fig. 1b). Gag and PH–Gag were further
processed by the viral proteases in the virions compared
with the cell lysates, as indicated by the increased signals
for CA and MA relative to Gag. Interestingly, approxi-
mately one-fifth of the PH–Gag in the virion was cleaved
close to the PH–MA junction. Presumably, the amino acid
sequence at the C end of the PH domain ELQN/FLKE (aa
164–171, where the protease cleaves at the N–F junction)
served as a viral protease recognition site as it matched the
substrate consensus sequence and resembled the NC–p1
junction, RQAN/FLGK (de Oliveira et al., 2003; Swanstrom
& Wills, 1997). Alternatively, the N terminus of LA–Gag
(EFTL/AADS) might be targeted by the viral protease.
Thus, the MA released from PH–MA, designated MA*,
possibly has 10 aa attached to its N terminus.
The VLP production efficiency was quantified as the
concentration of CA in transfected 293T cell culture
supernatants relative to that in cell lysates using a p24
ELISA (Zeptometrics). When the CA concentrations of the
virion fractions were normalized to those of the cell lysates,
the pPH-gag-pol viral production efficiency was 3.2-fold
higher than that of pgag-pol (3.2±2.0-fold, n514,
P,0.001 by Wilcoxon’s matched pairs rank test; repres-
entative experiments are shown in Table 1). In contrast,
pPH4A-gag-pol produced viral particles less efficiently than
pgag-pol (0.09±0.07-fold, n56, P,0.05 by Wilcoxon’s
matched pairs rank test; representative experiments are
shown in Table 1). These data were consistent with the
Western blot analysis (Fig. 1b).
To characterize the physical properties of PH–Gag–Pol
VLPs, we measured the specific density of virions and
examined the virion morphology. Firstly, the VLPs were
subjected to 20–70% (w/w) equilibrium sucrose gradient
centrifugation (120000 g for 16 h) and fractions were
recovered from the bottom to the top. The peak fraction
containing the viral CA antigen was determined by p24
ELISA. Gag–Pol and PH–Gag–Pol VLPs were detected in
fractions with densities of 1.15±0.01 (n55) and
1.16±0.01 (n54) g ml
21, respectively (not statistically
significant; representative experiments are shown in
Fig. 2a). Secondly, ultrathin sections of fixed 293T cells
(2% glutaraldehyde, 2% osmium tetroxide) transfected
with pgag-pol or pPH-gag-pol were imaged by transmission
electron microscopy (JEM1200EX at 80 kV or JEM2000EX
at 100 kV; JEOL). The PH–Gag–Pol and Gag–Pol VLP
Table 1. Efficiency of virus production from 293T cells transfected with pgag-pol, pPH-gag-pol or pPH4A-gag-pol expression vector
Experiment Plasmid p24
CA (ng per well)* Virus production
efficiency (B/A)
Fold increase
relative to pgag-pol
Cell lysate (A) Culture supernatant
(B)
1p gag-pol 4043 4869 1.204 –
pPH-gag-pol 1989 8363 4.206 3.49
pPH4A-gag-pol 3175 103 0.033 0.03
2p gag-pol 3521 3887 1.104 –
pPH-gag-pol 2638 7688 2.914 2.64
pPH4A-gag-pol 5913 1125 0.190 0.17
3p gag-pol 3359 4160 1.239 –
pPH-gag-pol 1454 5172 3.558 2.87
pPH4A-gag-pol 4226 75 0.018 0.01
4p gag-pol 9666 8996 0.931 –
pPH-gag-pol 4699 18273 3.889 4.18
pPH4A-gag-pol 5527 534 0.097 0.10
*Cells grown in six-well plates were transfected using Lipofectamine 2000 according to the manufacturer’s protocol (Invitrogen).
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structures showed that the electron-dense layer, which
represented multimerized Gag, of the PH–Gag–Pol VLP
was slightly separated from the viral envelope compared
with that of the Gag–Pol VLP (Fig. 2b). This indicated that
the PH domain was positioned between the viral envelope
and the electron-dense layer. In contrast, the morphologies
of the mature PH–Gag–Pol and Gag–Pol virions were
similar, suggesting that myristoylation is dispensable for
mature virion morphology and that the PH–Gag–Pol
virion may be infectious.
We examined HIV-1 Env incorporation into the PH–Gag–
Pol virion. To do this, we used codon-optimized gp160
(p96ZM651gp160-opt; NIH AIDS Research and Reference
Reagent Program). The PH–Gag–Pol virion incorporated
HIV-1 Env less efficiently than the Gag–Pol virion as
demonstrated by Western blot analysis detecting CA and
Fig. 2. Physical and biological properties of PH–Gag–Pol VLPs. (a) The virions produced by the pgag-pol (WT) and pPH-gag-
pol (PH) expression vectors were analysed by equilibrium sucrose density-gradient centrifugation. The virion-containing fraction
was determined by an ELISA detecting p24
CA. Representative data from four to five independent experiments are shown. In this
experiment, WT (filled circles) and PH (open circles) VLPs migrated in the 1.152 or 1.162 g ml
”1 density fractions, respectively.
(b) Transmission electron microscopy images of 293T cells transfected with pgag-pol (WT) or pPH-gag-pol (PH).
Representative images are shown. (c) Incorporation of HIV-1 Env (upper panel) and VSV-G (lower panel) into Gag–Pol (WT)
and PH–Gag–Pol (PH) virions. The virion fractions were subjected to Western blot analysis detecting gp120, VSV-G and
p24
CA. (d) The early phase of the HIV-1 life cycle is supported by PH–Gag–Pol. 293T cells were exposed to virus-containing
culture supernatants with similar CA concentrations (270 and 220 ng ml
”1 for Gag–Pol and PH–Gag–Pol, respectively), and
luciferase activities were measured at 2–3 days post-infection as relative light units (RLU). The luciferase activities of PH–Gag–
Pol (PH) and Gag–Pol (WT) virus-infected cells were almost identical (left graph). The luciferase transduction by WT (bars 1
and 2) and PH (bars 3 and 4) pseudovirions was performed in the presence of nevirapine (NVP, bars 1 and 3) or TAK-779 (bars
2 and 4). The luciferase signals decreased in the presence of NVP for both WT (bar 1) and PH (bar 3) but not in the presence of
TAK-779 for both WT (bar 2) and PH (bar 4), respectively. Representative data from several independent experiments are
shown. Asterisks indicate statistical significance (P,0.01, n53, Student’s t-test).
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Biotechnology; Fig. 2c). This was presumably because PH
interfered with the MA–Env interaction. Alternatively, PH
may actively incorporate cellular proteins that block
efficient Env incorporation into virions. We were unable
to evaluate the entry efficacy of PH–Gag–Pol virions
pseudotyped by HIV-1 Env because of the limit of
detection. PH–Gag–Pol virion infectivity was re-examined
by virions pseudotyped with vesicular stomatitis virus G
glycoprotein (VSV-G). The incorporation efficiencies of
VSV-G into Gag–Pol and PH–Gag–Pol virions were similar
(anti-VSV-G antibody from Sigma; Fig. 2c). The lentiviral
vector system was used to test this, as HIV-1 provirus gene
modifications often fail to produce infectious virions,
probably due to viral gene dysregulation. 293T cells were
transfected with expression plasmids for Gag–Pol, VSV-G
(Komano et al., 2004), Rev and Vpu (a generous gift from
Dr H. Go ¨ttlinger, University of Massachusetts Medical
School, MA, USA), and with a packaging vector encoding a
luciferase expression cassette. The HIV-1-based vector
expressing firefly luciferase upon infection was recovered
2 days post-transfection. 293T cells were exposed to virus-
containing culture supernatants with similar CA concen-
trations, and luciferase activities were measured at 2–3 days
post-infection. When viral preparations with similar p24
concentrations were used, the luciferase activities of PH–
Gag–Pol and Gag–Pol virus-infected cells were almost
identical to each other (Fig. 2d, left graph). Luciferase
expression was blocked by the non-nucleoside reverse
transcriptase inhibitor nevirapine (NVP; Boehringer
Ingelheim) but not by the CCR5 inhibitor (TAK-779;
NIH AIDS Research and Reference Reagent Program),
suggesting that gene transduction was mediated by viral
infection (Fig. 2d, right panel). Similar results were
obtained in several independent experiments. Thus, the
PLCd1 PH domain can functionally replace the HIV-1 Gag
myristoylation signal to support both viral production and
entry processes, and this myristoylation is dispensable for
MA function in the early phase of the virus life cycle. This
is the first report describing an infectious pseudovirion
without myristoylated Gag. Given that PH–Gag can
enhance virus production, HIV-1 with PH–Gag might
have been expected to be selected in nature. This is not the
case, presumably because the addition of PH to the HIV-1
genome would increase its genome size close to the upper
limit that can be incorporated into the retroviral particle,
leading to a decrease in genome uptake efficiency, which is
clearly a growth disadvantage, despite the enhanced virus
production with PH-Gag. More importantly, PH–Gag is
unable to incorporate HIV-1 Env efficiently enough to
support the production of fully infectious virions. Our data
point to the selective advantage of myristoylated Gag in
viral evolution.
The myristoylation-dependent Gag–PM association [max-
imal dissociation constant (Kd) of ~0.5–1.0610
25 M] is
presumably important for Gag multimerization at the PM
(Provitera et al., 2006). After the first contact of Gag with
the PM, the membrane binding of Gag is assumed to be
stabilized by the Gag–PI(4,5)P(2) interaction (Ono et al.,
2004; Saad et al., 2006). The multimerization of Gag
appears to induce a conformational change in MA to
expose myristoyl groups to enhance the PM targeting of
Gag. The higher-order Gag multimerization is probably
facilitated by the increased local concentrations of Gag at
the PM. Although Gag and PH–Gag are similar to the
extent that PI(4,5)P(2) is involved in their PM association,
Gag binds to one of the acyl chains of PI(4,5)P(2), as
modelled previously (Saad et al., 2006), whilst the PH
domain binds the phosphorylated inositol group (Lemmon
et al., 1995). The Kd of binding between the PLCd1P H
domain and PI(4,5)P(2) (~1–2610
26 M; Lemmon et al.,
1995) suggests that the primary force driving PH–Gag to
the PM is at least 2.5-fold stronger than that of
myristoylation-mediated PM targeting of Gag. This might
be one reason why PH–Gag–Pol was 3.2-fold more efficient
at virion production than Gag–Pol. Our data suggest that
the myristoyl group-dependent Gag–PM affinity is not a
prerequisite for efficient Gag assembly at the PM or for
viral production.
The MA has multiple functions throughout the virus life
cycle (reviewed by Bukrinskaya, 2007; Fiorentini et al.,
2006; Hearps & Jans, 2007; Klein et al., 2007). In the PH–
Gag–Pol virion, approximately one-fifth of the PH–MA
was unanchored from the PM as MA* (Fig. 1b), which
might accompany the pre-integration complex to support
nuclear targeting. Using PH–Gag–Pol might enable
separation of myristoylation-dependent and -independent
MA functions, particularly during the entry phase. PH–
Gag–Pol might also be useful for producing high-titre
lentiviral vectors or for studying Gag trafficking in cells
that poorly support PM targeting of myristoylated Gag,
such as rodent cells. Furthermore, functional assays
comparing the virus production of Gag–Pol and PH–
Gag–Pol might enable the identification of chemical
inhibitors or cellular factors specifically targeting myris-
toylated Gag.
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